Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
RESULTS:
Overall 12 original articles were included and critically evaluated. Sample sizes of patient actively treated with finasteride varied from 13 to 1524 cases analyzed in a single study. Follow-up after treatments ranged from 3 to 54 months. The effect of finasteride in reducing prostate volume (PV) was moderate (standardized mean difference (SMD) effect between 0.5 to 0.8 for all trials evaluable) while the effect on IPSS score and Qmax was considered significant (SMD in the 0.2 to 0.5 variation range). No severe AEs and/or psychiatric disorders were retrieved among the studies. Sexual health dysfunctions were significantly influenced by finasteride therapy when compared with placebo treated patients.
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
CONCLUSIONS AND RELEVANCE:
Available toxicity information from clinical trials of finasteride in men with AGA is very limited, is of poor quality, and seems to be systematically biased. In a cohort of men prescribed finasteride for routine treatment of AGA, most would have been excluded from the pivotal studies that supported US Food and Drug Administration approval for AGA. Published reports of clinical trials provide insufficient information to establish the safety profile for finasteride in the treatment of AGA.
Skip to 17:20 to hear what this famous endocrinologist has to say about the side effects.
Hell even Joe Rogan experienced sides:
Finasteride has been added to the ‘list of drugs to avoid in 2021’ by a French Medical Journal
Translation from the Journal ‘Drugs to be Avoided for Better Care 2021 Report’
‘Finasteride 1mg, a 5-alpha-reductase inhibitor, has a very high efficacy in modest androgenic alopecia in men: it increases hair density only slightly on the top of the head (by about 10%), and only for the duration of the treatment. It exposes particular sexual disorders (e.g., sexual dysfunction in erection and ejaculation, decreased libido), depression, suicidal ideation and cancer of the breast. When a drug is the chosen option, local minoxidil used with care is less dangerous.’
(Finasteride is on page 6 of the journal)
The journal is called Prescrire, a medical journal that ‘addresses developments in diseases, medications, and in medical techniques and technologies’ and ‘contains no advertising’.
According to their website their ‘editors are healthcare professionals, specially trained in Prescrire’s editorial methods and free from conflicts of interest. Exacting quality control procedures are applied to all editorial content.’
internet is full of doctors talking about PFS.
View: https://twitter.com/i/web/status/1324770761731657734
“Definitely seen this a lot and believe it’s real. Anecdotally feel symptoms are worse the younger they started on finasteride. Clomid has helped on a few pts with lower T / FSH/LH levels…”
View: https://twitter.com/i/web/status/1333240440003420160
“And I’m 100% certain this effects older guys as well…it’s just more obvious in the younger guys who typically have no co-morbidities.”
View: https://twitter.com/i/web/status/1327387622688354305
“Post finasteride syndrome is so real! Hundreds of patients coming to #sandiegosexualmedicine with this. Often have low t. Make sure to check dht also! Some recommend andractim, available in Europe (and online). Shockwave therapy for ED. Can take years to get better for some!”